LGALS1 and neoplasm: Wu et al. have shown that targeting Galectin-1 to significantly inhibit CAF-conditioned medium-induced tumor cell migration and invasion in oral squamous cancer cells (OSCCs) resulting in a reduced metastasis in vivo [96].